- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00444327
Use Cord Blood Single Nucleotide Polymorphism to Predict the Later Development of Atopy and Allergy
May 13, 2009 updated by: Min-Sheng General Hospital
Observational Study of Cord Blood Single Nucleotide Polymorphisms of Genes Related to Atopy and Allergic Diseases
The aim of our study was firstly to detect in cord bloods the polymorphism of genes related to atopy and allergic diseases and to examine their mutual interaction and their associations with cord blood IgE and cytokines.
After that, in the prospective follow-up visits, we liked to investigate if the measurement of cord blood SNPs of genes related to atopy and allergic diseases was helpful in predicting the development of atopy and allergic diseases later in life.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
900
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Chien-Han Chen, M.D.
- Phone Number: 2007 886-3-3179599
- Email: chinsword@yahoo.com.tw
Study Locations
-
-
-
Taoyuan, Taiwan
- Not yet recruiting
- Min-Sheng General Hospital
-
Principal Investigator:
- Chien-Han Chen, M.D.
-
Taoyuan, Taiwan
- Recruiting
- Min-Sheng General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 1 minute (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
hospital and primary care clinic based study
Description
Inclusion Criteria:
- Apgar score of 5 minutes not less than 7 gestational age not less than 36 weeks
Exclusion Criteria:
- Apgar score of 5 minutes < 7 gestational age < 36 weeks
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Chien-Han Chen, M.D., Min-Sheng General Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2007
Study Registration Dates
First Submitted
March 6, 2007
First Submitted That Met QC Criteria
March 6, 2007
First Posted (Estimate)
March 7, 2007
Study Record Updates
Last Update Posted (Estimate)
May 14, 2009
Last Update Submitted That Met QC Criteria
May 13, 2009
Last Verified
May 1, 2009
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2007005
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atopy
-
Allakos Inc.Completed
-
Min-Sheng General HospitalUnknown
-
Seoul National University HospitalMinistry of Health & Welfare, KoreaCompletedAsymptomatic Subjects With Atopy and Elevated Serum IgEKorea, Republic of
-
Centre Hospitalier Universitaire de BesanconCompleted
-
Beth Israel Deaconess Medical CenterNovartisWithdrawnAutism Spectrum Disorder | AtopyUnited States
-
Agentschap NLAmsterdam UMC, location VUmc; Danone ResearchUnknownEczema | Microbiota | AtopyNetherlands
-
Organon and CoCompletedChronic Idiopathic Urticaria | Atopy
-
Universidade do PortoCompletedAsthma | AtopyPortugal
-
Sydney LeibelActive, not recruiting
-
Massachusetts General HospitalNational Heart, Lung, and Blood Institute (NHLBI)Completed